Welcome to the post-event wrap-up of the largest TIDES event to date. On May 14-17, 2024, more than 1900 attendees from across the global oligo, peptide, mRNA, and genome editing community gathered in Boston, Massachusetts, to discuss the latest cutting-edge strategies to accelerate molecules to market.
The TIDES US agenda encompassed over 150 of the industry's top scientists to present the latest science and industry updates across the entire spectrum from discovery, preclinical, and clinical development through CMC, Manufacturing, and commercialization of therapeutics and vaccines for oligos, peptides, and mRNA and genome editing products.
Our 2024 content cross-pollinated expertise across the spectrum of Oligonucleotides, Peptides, mRNA, and Genome Editing. The TIDES USA 2024 program featured concurrent tracks covering 6 scientific themes including in-depth development strategies, trends, and technologies across oligonucleotides, peptides, mRNA, and genome editing spaces.
This eBook highlights key moments of the event and looks at the significance of the research and insights shared in Boston this year. Read on to get a sense of what the buzz was like on-site and learn more about the industry-shaping discussions that were shared at TIDES US.
We hope to see you next year at TIDES US on May 19-22, 2025, at the Manchester Grand Hyatt in San Diego, CA.
Click to read eBook: Innovations in Oligonucleotide and Peptide CMC Post-Event Report
